Alprazolam
1.
Alpragen contains the active substance alprazolam, which belongs to a group of medicines called benzodiazepines.
Alpragen is indicated for the treatment of anxiety disorders in adults, only in situations where symptoms are severe, interfere with normal functioning, or are very troublesome for the patient. This medicine is intended for short-term use only.
Before starting treatment with Alpragen, discuss it with your doctor or pharmacist
During treatment with Alpragen, anterograde amnesia may occur in the patient. To reduce the risk, the patient should have uninterrupted sleep for 7-8 hours during treatment.
Alprazolam use has been associated with the occurrence of atypical reactions, such as: anxiety, especially motor, agitation, irritability, aggression, delusions, outbursts of anger, nightmares, hallucinations (seeing or hearing things that do not exist), psychosis (loss of contact with reality) and bizarre behavior. If such symptoms occur , you should consult a doctor, as it will be necessary to
stop taking the medicine.
Alpragen is not recommended for children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take, including those available without a prescription. It is especially important to inform your doctor about taking medicines such as:
Taking Alpragen with opioids (strong painkillers, medicines used in substitution therapy for drug addiction, some cough medicines) increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening.
Deaths have been reported. For this reason, concurrent use should only be considered when other treatment methods are not possible.
However, if the doctor prescribes Alpragen with opioids, the dosage and duration of such treatment should be limited by the attending physician.
You should inform your doctor about all opioid medicines you are taking and strictly follow the dosage prescribed by your doctor. It may be helpful to inform friends or family about the above symptoms. If such symptoms occur, you should contact your doctor.
In case of planned surgery under general anesthesia, you should inform your doctor about taking alprazolam.
You must not drink alcohol while taking Alpragen; alcohol enhances the effect of Alpragen.
You should not drink too much grapefruit juice while taking this medicine, as it may increase the amount of alprazolam in the blood.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine. You should not
take Alpragen if you are pregnant without discussing the possible risks and benefits with your doctor.
If alprazolam is taken regularly in the last trimester of pregnancy, the baby may become dependent on alprazolam and experience withdrawal symptoms after birth.
If the doctor decides to use alprazolam in late pregnancy or during childbirth, the baby may experience symptoms such as low body temperature, weakness, breathing difficulties, and feeding problems, tremors, increased excitability, and agitation.
You should not take Alpragen while breastfeeding, as this medicine may pass into breast milk.
You should not drive or operate machinery after taking alprazolam, as it may cause symptoms such as: loss of concentration, loss of muscle control, memory loss, dizziness, drowsiness, or confusion.
If you have been diagnosed with intolerance to some sugars, you should consult your doctor before taking Alpragen.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
The medicine contains 0.1 mg of sodium benzoate per tablet.
Sodium benzoate may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of age), but this medicine is not recommended for use in patients under 18 years of age.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is 0.25 mg to 0.5 mg three times a day.
If necessary, your doctor may decide to increase the dose to a maximum of 4 mg per day. If in doubt, consult your doctor or pharmacist again. You should be cautious when increasing the dose. You should first increase the evening dose, and then the daily dose.
In patients who have not taken this type of medicine before and in patients with a history of alcoholism, a lower dose should be used.
The recommended dose for elderly patients is 0.25 mg two to three times a day. In elderly patients in good physical condition, the doctor may increase the dose by 0.5 mg every third day, up to a maximum dose of 1.5 mg per day. In frail elderly patients, the dose should not exceed 0.75 mg per day.
Alpragen should be taken orally. The score line on the tablet is only to facilitate breaking the tablet to make it easier to swallow.
In case of liver or kidney impairment, the doctor may recommend a lower dose than usual. The maximum recommended dose for patients with liver or kidney impairment is 0.75 mg to 1.5 mg per day.
Alpragen should not be taken for longer than prescribed by your doctor. The total treatment duration should not exceed 2-4 weeks. Taking alprazolam for too long and in too high a dose may lead to the development of psychological and physical dependence. Do not stop treatment prematurely.
If you have taken more than the recommended dose contact your doctor or go to the emergency department of your nearest hospital immediately. Take the medicine packaging and any remaining tablets with you. Symptoms of overdose include: drowsiness, confusion, lack of coordination or unsteady movements, breathing difficulties, low blood pressure, fatigue, loss of consciousness, and in rare cases, death.
Do not take a double dose to make up for a missed dose, just take the next dose at the right time.
Do not stop treatment on your own. Before stopping treatment, the doses of the medicine should be gradually reduced. Your doctor will tell you how to do this. If you stop taking Alpragen or stop treatment too early, you may experience symptoms such as: anxiety, restlessness, especially motor, seizures, headaches, muscle pain, tension, confusion, irritability, involuntary movements, and difficulty sleeping.
In severe cases, symptoms may also include loss of consciousness, loss of contact with reality, increased sensitivity to light, sound, and touch, feeling of numbness or tingling in the limbs, seeing or hearing things that do not exist, seizures, abdominal cramps, and muscle spasms, vomiting, sweating, and shivering.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Alpragen can cause side effects, although not everybody gets them.
In people with a history of violence, borderline personality disorders, alcohol abuse, and people taking medicines that affect the central nervous system, hostile or aggressive behavior has been observed. If the patient has post-traumatic stress disorder, stopping treatment with Alpragen may cause irritability, hostility, and unpleasant thoughts and reflections.
Common side effects are usually observed at the beginning of treatment with Alpragen. These symptoms usually disappear during continued treatment.
You should tell your doctor immediatelyif you experience any of the following side effects, as they can be serious:
Uncommon(may affect up to 1 in 100 people)
Side effects with unknown frequency(frequency cannot be estimated from available data)
Stop taking the medicine. Your doctor will tell you how to do this.
Other side effects
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Side effects with unknown frequency(frequency cannot be estimated from available data)
If you experience any side effects, including those not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Jerozolimskie Avenue 181C, phone: 22 49 21 301, fax: 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 25°C. Store in the original packaging to protect from light and moisture.
“EXP”.The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
0.25 mg tablets: white, oval tablets with the inscription "AL" score line "0.25" on one side and "G" on the other side.
0.5 mg tablets: pink, oval tablets with the inscription "AL" score line "0.5" on one side and "G" on the other side.
1 mg tablets: light blue, oval tablets with the inscription "AL" score line "1.0" on one side and "G" on the other side.
Alpragen is available in packs containing 30 or 60 tablets in blisters.
Not all pack sizes may be marketed.
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
DUBLIN
Ireland
Manufacturer
McDermott Laboratories Ltd., trading as Gerard Laboratories Ltd.
35/36 Baldoyle Industrial Estate
Grange Road, Dublin 13
Ireland
Mylan Hungary Kft.
Mylan utca 1.
Komárom, 2900
Hungary
To obtain more detailed information, please contact the representative of the marketing authorization holder:
phone: +48 22 54 66 400
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.